We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Defect in Protein Glycosylation Linked to Muscular Dystrophy

By Biotechdaily staff writers
Posted on 01 Jul 2004
Researchers have found that a mutation in the gene that encodes the glycosyltransferase called LARGE is present in diseases similar to muscular dystrophy, and by genetically engineering overexpression of the normal gene, it is possible to restore normal muscle cell function. More...


Investigators at the University of Iowa (Iowa City, USA) worked with a mouse model that lacked the gene for LARGE. Failure of proper transfer of sugar molecules to the muscle cell protein alpha-dystroglycan caused these animals to display symptoms similar to muscular dystrophy in humans.

When the gene for LARGE was transferred into these animals, normal protein glycosylation was restored and symptoms disappeared. These findings and other observations about LARGE were reported in the June 3, 2004, online edition of Cell and the June 6, 2004, online edition of Nature Medicine.

Senior author Dr. Kevin Campbell, professor of neurology at the University of Iowa, said, "The finding that LARGE can restore alpha-dystroglycan function regardless of the type of glycosylation defect is incredibly exciting. This result may have potential application in the development of therapies for an entire group of muscle diseases.”

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.